Works in Cancer Chemotherapy & Pharmacology, 2010, Vol 66, Issue 6
Results: 22
Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1031, doi. 10.1007/s00280-010-1253-9
- By:
- Publication type:
- Article
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1019, doi. 10.1007/s00280-010-1252-x
- By:
- Publication type:
- Article
Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1013, doi. 10.1007/s00280-010-1251-y
- By:
- Publication type:
- Article
Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1095, doi. 10.1007/s00280-010-1267-3
- By:
- Publication type:
- Article
Resistance to platinum-based chemotherapy in lung cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1103, doi. 10.1007/s00280-010-1268-2
- By:
- Publication type:
- Article
Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1123, doi. 10.1007/s00280-010-1270-8
- By:
- Publication type:
- Article
Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1087, doi. 10.1007/s00280-010-1266-4
- By:
- Publication type:
- Article
Sonodynamically induced apoptosis and active oxygen generation by gallium-porphyrin complex, ATX-70.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1071, doi. 10.1007/s00280-010-1264-6
- By:
- Publication type:
- Article
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1131, doi. 10.1007/s00280-010-1455-1
- By:
- Publication type:
- Article
Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1141, doi. 10.1007/s00280-010-1449-z
- By:
- Publication type:
- Article
Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1151, doi. 10.1007/s00280-010-1456-0
- By:
- Publication type:
- Article
Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study.
- Published in:
- 2010
- By:
- Publication type:
- Report
Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1005, doi. 10.1007/s00280-010-1467-x
- By:
- Publication type:
- Article
A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1051, doi. 10.1007/s00280-010-1257-5
- By:
- Publication type:
- Article
Bendamustine pharmacokinetic profile and exposure-response relationships in patients with indolent non-Hodgkin's lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1039, doi. 10.1007/s00280-010-1254-8
- By:
- Publication type:
- Article
Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1059, doi. 10.1007/s00280-010-1259-3
- By:
- Publication type:
- Article
An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1065, doi. 10.1007/s00280-010-1262-8
- By:
- Publication type:
- Article
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1079, doi. 10.1007/s00280-010-1265-5
- By:
- Publication type:
- Article
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1113, doi. 10.1007/s00280-010-1269-1
- By:
- Publication type:
- Article
Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1173, doi. 10.1007/s00280-010-1406-x
- By:
- Publication type:
- Article
Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1167, doi. 10.1007/s00280-010-1403-0
- By:
- Publication type:
- Article